Treatments for Pulmonary Hypertension

Below is a listing of treatments and therapies for pulmonary hypertension. Click on one to read more information or connect with others currently using it.

View:
  • Adcirca (Tadalafil)

    Overview
    Adcirca is a prescription drug approved by the Food and Drug Administration (FDA) to improve exercise in cases of pulmonary arterial hypertension. Adcirca may be referred to by its drug name, Tadalafi... read more

  • Adempas (Riociguat)

    Overview
    Adempas is a prescription drug approved by the Food and Drug Administration (FDA) to improve exercise and function in adult cases of chronic thromboembolic pulmonary hypertension
    (CTEPH) and pulmonar... read more

  • Aldactone (Spironolactone)

    Overview
    Aldactone is a prescription drug approved by the Food and Drug Administration (FDA) to treat hypertension, heart failure, edema, and other conditions. In cases of pulmonary hypertension, Aldactone may... read more

  • Atrial septostomy

    Overview
    Some people with advanced pulmonary arterial hypertension (PAH) and severe right heart failure may be candidates for atrial septostomy surgery. Atrial septostomy can relieve pressure in the right side... read more

  • Bumex (Bumetanide)

    Overview
    Bumex is a prescription drug approved by the Food and Drug Administration (FDA) to treat edema associated with congestive heart failure and other conditions. In cases of pulmonary hypertension, Bumex ... read more

  • Cardizem (Diltiazem)

    Overview
    Cardizem is a prescription drug approved by the Food and Drug Administration (FDA) to treat chronic stable angina and angina due to coronary artery spasm. Cardizem may also be prescribed to treat case... read more

  • Clinical trials

    Overview
    Depending on several factors, you may be eligible to participate in clinical trials studying new treatments for pulmonary hypertension. Eligibility may be based on specifics of your condition, such as... read more

  • Coumadin (Warfarin)

    Overview
    Coumadin is a prescription drug approved by the Food and Drug Administration (FDA) to treat and prevent thromboembolic events. Coumadin may also be prescribed in cases of pulmonary hypertension, espec... read more

  • Digoxin

    Overview
    Digoxin is a prescription drug approved by the Food and Drug Administration (FDA) to treat mild to moderate heart failure and atrial fibrillation. Digoxin may also be prescribed in cases of pulmonary ... read more

  • Exercise

    Overview
    Years ago, doctors used to believe that people with pulmonary hypertension (PH) should avoid exercise as dangerous to their health. More recently, most PH specialists have come to believe that regular... read more

  • Flolan (Epoprostenol)

    Overview
    Flolan is a prescription drug approved by the Food and Drug Administration (FDA) to improve exercise capacity in cases of pulmonary arterial hypertension (PAH). Flolan may be referred to by its drug n... read more

  • Heart-lung transplant

    Overview
    Heart-lung transplant may be an option for some people with end-stage heart and lung disease due to pulmonary hypertension (PH). However, heart-lung transplant also poses significant risk for serious ... read more

  • Lanoxin (Digoxin)

    Overview
    Lanoxin is a prescription drug approved by the Food and Drug Administration (FDA) to treat mild to moderate heart failure and atrial fibrillation in adults. Lanoxin may also be prescribed in cases of ... read more

  • Lasix (Furosemide)

    Overview
    Lasix is a prescription drug approved by the Food and Drug Administration (FDA) to treat hypertension and edema associated with congestive heart failure and other conditions. In cases of pulmonary hyp... read more

  • Letairis (Ambrisentan)

    Overview
    Letairis is a prescription drug approved by the Food and Drug Administration (FDA) to improve exercise capacity and limit disease progression in cases of pulmonary arterial hypertension (PAH). Letairi... read more

  • Lung transplant

    Overview
    Lung transplant can prolong survival and improve lung function and quality of life in some people with pulmonary hypertension (PH). However, lung transplant also poses significant risk for serious com... read more

  • Metolazone

    Overview
    Metolazone is a prescription drug approved by the Food and Drug Administration (FDA) to treat hypertension and edema associated with congestive heart failure. In cases of pulmonary hypertension, Metol... read more

  • Mitral valve surgery

    Overview
    In some people with pulmonary hypertension (PH), the disease is caused by damage or a defect of the mitral valve of the heart. Mitral valve surgery can potentially be an effective treatment for PH in ... read more

  • Nutrition

    Overview
    Like everyone else, people with pulmonary hypertension (PH) feel their best when they consistently eat a healthy, balanced diet. By choosing the right foods, people with PH can improve disease symptom... read more

  • Opsumit (Macitentan)

    Overview
    Opsumit is a prescription drug approved by the Food and Drug Administration (FDA) to delay disease progression in cases of pulmonary arterial hypertension (PAH). Opsumit may be referred to by its drug... read more

  • Orenitram (Treprostinil)

    Overview
    Orenitram is a prescription drug approved by the Food and Drug Administration (FDA) to improve exercise capacity in cases of pulmonary arterial hypertension (PAH). Orenitram may be referred to by its ... read more

  • Oxygen therapy

    Overview
    People with pulmonary hypertension caused by conditions such as chronic obstructive pulmonary disease (COPD), interstitial lung disease, and sleep apnea may develop hypoxia, or low levels of oxygen in... read more

  • Procardia (Nifedipine)

    Overview
    Procardia is a prescription drug approved by the Food and Drug Administration (FDA) to manage vasospastic angina and chronic stable angina. Procardia may also be prescribed to treat cases of pulmonary... read more

  • Pulmonary rehabilitation

    Overview
    People with pulmonary hypertension (PH) may develop shortness of breath that makes it difficult to walk and perform other daily activities. Pulmonary rehabilitation is a program designed to improve yo... read more

  • Pulmonary thromboendarterectomy (PTE)

    Overview
    Pulmonary thromboendarterectomy (PTE) surgery is a potential cure for some people with chronic thromboembolic pulmonary hypertension (CTEPH). CTEPH is a type of pulmonary hypertension wherein blood cl... read more

  • Remodulin (Treprostinil)

    Overview
    Remodulin is a prescription drug approved by the Food and Drug Administration (FDA) to improve exercise capacity in cases of pulmonary arterial hypertension (PAH). Remodulin is sometimes prescribed wh... read more

  • Revatio (Sildenafil)

    Overview
    Revatio is a prescription drug approved by the Food and Drug Administration (FDA) to improve exercise and delay disease progression in cases of pulmonary arterial hypertension. Revatio may be referred... read more

  • Sildenafil

    Overview
    Sildenafil is a prescription drug approved by the Food and Drug Administration (FDA) to improve exercise and delay disease progression in cases of pulmonary arterial hypertension. Sildenafil is sold u... read more

  • Tracleer (Bosentan)

    Overview
    Tracleer is a prescription drug approved by the Food and Drug Administration (FDA) to improve exercise capacity and limit disease progression in cases of pulmonary arterial hypertension (PAH). Traclee... read more

  • Tyvaso (Treprostinil)

    Overview
    Tyvaso is a prescription drug approved by the Food and Drug Administration (FDA) to improve exercise capacity in cases of pulmonary arterial hypertension (PAH). Tyvaso may be referred to by its drug n... read more

  • Uptravi (Selexipag)

    Overview
    Uptravi is a prescription drug approved by the Food and Drug Administration (FDA) to delay disease progression and reduce the risk of hospitalization in cases of pulmonary arterial hypertension (PAH).... read more

  • Veletri (Epoprostenol)

    Overview
    Veletri is a prescription drug approved by the Food and Drug Administration (FDA) to improve exercise capacity in cases of pulmonary arterial hypertension (PAH). Veletri may be referred to by its drug... read more

  • Ventavis (Iloprost)

    Overview
    Ventavis is a prescription drug approved by the Food and Drug Administration (FDA) to improve symptoms and exercise capacity and to avoid deterioration in cases of pulmonary arterial hypertension (PAH... read more

Continue with Facebook
Sign up with your email
Already a Member? Log in
×

Welcome back!

Log in to gain access to the thousands of comments being shared on myPHteam.

log in
×